biomarkers

(redirected from biomarker)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms, Wikipedia.

biomarkers

[′bī·ō‚mär·kərz]
(geology)
Complex organic compounds found in oil, bitumen, rocks, and sediments that are linked with and distinctive of a particular source (such as algae, bacteria, or vascular plants); they are useful dating indicators in stratigraphy and molecular paleontology. Also known as chemical fossils; molecular fossils.
References in periodicals archive ?
the cancer biomarkers market on the basis of cancer type is classified into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-hodgkin's lymphoma, kidney, and other cancers, such as cervical, multiple myeloma, and CNS, gastric, liver, pancreatic, oral cavity and pharynx, stomach, and ovarian cancers.
Joint Session: Clinical Utility of Diagnostic & Screening Biomarkers
Specificity: The proportion of control (normal) individuals who test negative for the biomarker.
Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.
Chapter 5, biomarkers in health care, starts a pattern of organization characterized by paragraphs detailing individual biomarkers by disease states and organ system.
The appropriate timing of measuring a biomarker depends on the pre-test probability of the outcome and half-life of the biomarker.
Demonstrating a link between chemical exposure and gene expression profiles could pave the way for the use of carcinogen-induced changes in transcription as biomarkers to assess worker risk.
On the basis of indications, the biomarkers market is segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.
According to the report, even though most surveyed oncologists across the EU5 currently test their patients for the presence of biomarkers such as KRAS- and EGFR-mutations, they indicate that obtaining tumour biopsies of adequate quality and size can limit biomarker testing.
Environmental Protection Agency (EPA) Office of Research and Development, National Center for Environmental Research (NCER), through its Science to Achieve Results (STAR) program, is issuing this request for applications (RFA) for research that provides validation, interpretation, and/or application of currently known biomarkers to environmental health and risk assessment.
Biomarker technology is used to understand the molecular mechanism of action of novel drugs in humans, provide insights into their pharmacological properties, measure their biological effect (e.
According to the Food and Drug Administration (FDA), a biomarker is a characteristic that can be objectively measured and evaluated as an indicator of biologic processes, or as biological responses to a therapeutic treatment, generally existing as specific enzyme or hormone concentrations.